Entering the US skincare market means working inside a framework that changed with MoCRA, a significant update to US cosmetic rules in decades. The short answer for a new brand: most cosmetics do not need individual pre-market approval, but MoCRA adds facility registration, product listing, safety substantiation, and recordkeeping duties that reshape how a brand plans a compliant launch. Approach these as launch readiness, not paperwork filed after sales begin. The brands that launch cleanest are usually the ones that built these steps into the formula and packaging plan from the start.
What Does MoCRA Actually Change for a Skincare Brand?
MoCRA, signed into law in 2022, expanded FDA’s authority over cosmetics in a way not seen in decades. It introduced facility registration, product listing, adverse-event recordkeeping, safety substantiation, and updated labeling expectations. Several requirements are being implemented in phases, and FDA has adjusted timelines, so the practical approach is to follow current FDA guidance rather than a fixed launch date. A brand planning 12 to 18 months out should build flexibility into its timeline because specific obligations continue to take shape.
Do You Need Approval Before Selling Cosmetics in the US?
For ordinary cosmetics, no individual product approval is required before sale. This differs from drugs, which follow a separate regulatory path with pre-market review. A common mistake is to imply that the agency pre-clears cosmetics; standard skincare is not individually cleared before launch, and labels should not suggest otherwise. What changed is not a pre-market gate but a broader set of post-market and registration duties.
Which Registration and Listing Steps Apply to Your Supply Chain?
MoCRA places registration and listing obligations on facilities and on the products placed on the US market. For a brand working with a contract manufacturer, the manufacturing site typically handles facility registration, while the responsible party handles product listing. Each product and its variants generally need to be listed with the responsible party identified. Mapping these duties early avoids last-minute gaps before a launch window, and your manufacturer’s registration status should be confirmed in writing before you commit to a launch date.
Why Does MoCRA Matter When Choosing a Contract Manufacturer?
Your manufacturer’s registration status is part of your own compliance picture. A contract manufacturer that already handles US registrations can reduce the steps you manage directly, while one new to the US market may need more hand-holding. Ask early whether the site is registered, how product listing is split between you and the factory, and who holds the substantiation file. These answers shape both your timeline and your responsible-party plan, so they belong in the supplier shortlist rather than a late-stage review.
What Is Safety Substantiation and Who Owns It?
Safety substantiation means the responsible person holds and can point to evidence that a product is safe under its labeled use. MoCRA frames this as an obligation, and brands should build it into launch readiness rather than leave it as an afterthought. The evidence does not need to be a single document; it can include testing, published data, and a reasoned assessment. Building the substantiation file alongside formula development keeps the launch coherent and makes later questions from retailers or regulators easier to answer.
How Do Claims Decide Your Regulatory Path?
Claims, not ingredients alone, often decide the regulatory route. A product positioned and labeled as a cosmetic follows the cosmetic framework; a product that makes drug-type claims, for example claims that it is intended to affect the body in a drug-like way, follows a different path. Keeping claim language within cosmetic boundaries is a practical way to keep a launch predictable. Before finalizing copy, review every claim against the cosmetic versus drug line, because a single drug-type claim can move the whole product into a heavier regime.
What Labeling Changes Should Brands Expect?
MoCRA also points toward updated labeling expectations, including clearer responsible-person information on the label. Brands should review their label layout early so that required identifiers have a place, rather than redesigning packaging close to launch. Ingredient listing and any required disclosures should be checked against both federal and state expectations, since some states add their own labeling rules.
What State-Level Rules Should You Plan For?
Federal rules are not the whole picture. Some states add their own requirements, such as ingredient disclosure or warning-label obligations, and these vary by state. A brand selling through national retail or ecommerce may touch several states at once, so the compliance view should be multi-state rather than federal-only. Build a list of the states where you actually sell, then check each for cosmetics-specific obligations. Keep this list current, because state rules can shift between planning and launch.
How Should You Structure Your US Responsible Party and Import Setup?
Importing cosmetics into the US involves customs clearance and a responsible-party arrangement for communication with regulators. Deciding who serves as the responsible person, the brand, its US entity, or a designated agent, affects both compliance and day-to-day operations. The responsible party is the contact point for records and questions, so it should be an entity that can actually respond. Aligning this with your contract manufacturer’s registration plan keeps the launch coherent, and it should be settled before inventory ships.
Note: This article summarizes market-entry considerations and is not legal advice. Requirements evolve, and the responsible party should confirm current obligations with qualified regulatory counsel and FDA’s published guidance.
How Can CHONGSHENG FUTURE (重生未来) Support a Compliant Launch?
Planning a US skincare launch is easier when formulation, documentation, and manufacturing are built with export in mind. CHONGSHENG FUTURE (重生未来) works with overseas brands on OEM and ODM skincare development, including documentation support that helps responsible parties meet listing and substantiation expectations. If you are mapping a US entry, talk to our team about a formulation and compliance-ready roadmap.